ES2062336T3 - Derivados de benzoxepina. - Google Patents

Derivados de benzoxepina.

Info

Publication number
ES2062336T3
ES2062336T3 ES90302745T ES90302745T ES2062336T3 ES 2062336 T3 ES2062336 T3 ES 2062336T3 ES 90302745 T ES90302745 T ES 90302745T ES 90302745 T ES90302745 T ES 90302745T ES 2062336 T3 ES2062336 T3 ES 2062336T3
Authority
ES
Spain
Prior art keywords
formula
chem
benzoxepine derivatives
benzoxepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90302745T
Other languages
English (en)
Inventor
Toshio Tatsuoka
Makoto Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2062336T3 publication Critical patent/ES2062336T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

UN DERIVADO DE BENZOXEPINA REPRESENTADO POR LA FORMULA (I) DONDE R REPRESENTA UN GRUPO HETEROCICLICO Y SALES DEL MISMO, UN PROCESO PARA PRODUCCION DE ESTE COMPRENDE LOS PASOS DE: REDUCIR UN OXIMA REPRESENTADO POR LA FORMULA (V) DONDE R TIENE EL SIGNIFICADO YA DEFINIDO EN LA FORMULA (I) Y LA HIDROLIZACION DEL INTERMEDIRARIO PRODUCIDO POR LA REDUCCION ANTERIOR, Y FARMACOS QUE COMPRENDE EL COMPUESTOS (I).
ES90302745T 1989-03-15 1990-03-14 Derivados de benzoxepina. Expired - Lifetime ES2062336T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1061040A JP2851054B2 (ja) 1989-03-15 1989-03-15 ベンズオキセピン誘導体

Publications (1)

Publication Number Publication Date
ES2062336T3 true ES2062336T3 (es) 1994-12-16

Family

ID=13159742

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90302745T Expired - Lifetime ES2062336T3 (es) 1989-03-15 1990-03-14 Derivados de benzoxepina.

Country Status (7)

Country Link
US (1) US5041444A (es)
EP (1) EP0388188B1 (es)
JP (1) JP2851054B2 (es)
AT (1) ATE100097T1 (es)
DE (1) DE69005861T2 (es)
DK (1) DK0388188T3 (es)
ES (1) ES2062336T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006026430A2 (en) 2004-08-27 2006-03-09 Infinity Pharmaceuticals, Inc. Cyclopamine analogues and methods of use thereof
ITMI20042168A1 (it) * 2004-11-12 2005-02-12 Erregierre Spa Processo di preparazione di itopride cloridrato
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
JP2010520295A (ja) 2007-03-07 2010-06-10 インフィニティ・ディスカバリー・インコーポレイテッド へテロ環状シクロパミン類似体及びその使用方法
KR20090117956A (ko) 2007-03-07 2009-11-16 인피니티 디스커버리, 인코포레이티드 시클로파민 락탐 유사체 및 그의 사용 방법
EP2224807B1 (en) 2007-12-27 2016-11-09 Infinity Pharmaceuticals, Inc. Methods for stereoselective reduction
EP2247587B1 (en) * 2008-03-01 2014-03-26 Merck Patent GmbH 5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2
ES2567134T3 (es) 2009-08-05 2016-04-20 Infinity Pharmaceuticals, Inc. Transaminación enzimática de análogos de ciclopamina
US9376447B2 (en) 2010-09-14 2016-06-28 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
WO2016019587A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [7, 6]-fused bicyclic antidiabetic compounds
WO2016196928A1 (en) 2015-06-04 2016-12-08 PellePharm, Inc. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766212A (en) * 1983-02-15 1988-08-23 Merrell Dow Pharmaceuticals Inc. 2H-[1]benzoxepino[5,4-b]-1,4-oxazine derivatives
AU597671B2 (en) * 1986-06-20 1990-06-07 Suntory Limited 2-Phenylbenzoxepin derivative

Also Published As

Publication number Publication date
JPH02243687A (ja) 1990-09-27
DK0388188T3 (da) 1994-02-14
US5041444A (en) 1991-08-20
DE69005861T2 (de) 1994-04-28
JP2851054B2 (ja) 1999-01-27
EP0388188A1 (en) 1990-09-19
DE69005861D1 (de) 1994-02-24
ATE100097T1 (de) 1994-01-15
EP0388188B1 (en) 1994-01-12

Similar Documents

Publication Publication Date Title
PT872481E (pt) Derivado de depsipéptido, processo para a sua produção, e novos intermediários do mesmo
HU9401415D0 (en) Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them
DE69637747D1 (de) Zuckerverbindungen
ES2062336T3 (es) Derivados de benzoxepina.
AU8163091A (en) Novel tricyclic compound or salts thereof, method for producing the same and antimicrobial agent containing the same
AU5835190A (en) Antitumor substance be-13793c
ES2144013T3 (es) Derivado de la vitamina d y procedimiento para su produccion.
ATE141583T1 (de) Alpha-methylencyclopentanon-derivate und verfahren zu ihrer herstellung
PL288793A1 (en) Method of obtaining novel compounds
EP0250755A3 (en) Fluorine derivatives of vitamin d3 and process for producing the same
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
EP1132375A4 (en) AMINOACRYLIC ACID DERIVATIVES AND PROCESS FOR PRODUCING THE SAME
EP0955376A4 (en) ANTIBIOTIC TKR 459, PRODUCTION METHOD THEREOF AND MICROORGANISM
ATE298744T1 (de) Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel
CA2122705A1 (en) Optically Active 1-Phenylpyrrolidone Derivative, Intermediate for Producing the Same, and Process for Producing Both
AU7535287A (en) A method for epimerizing an optically active benzylalcohol derivative
DE69000335D1 (de) Butalactin, verfahren zu seiner herstellung und seine verwendung als arzneimittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 388188

Country of ref document: ES